ResoluteAI Launches Clinical Trial Analytics

Connects and Analyzes Clinical Trial Data with Research Publications

NEW YORK--(BUSINESS WIRE)--ResoluteAI, the research platform for science, launched today a Clinical Trials Analytics package that connects clinical trial data with research publications and other datasets. Clinical research and development professionals and medical affairs specialists can now assess and evaluate risk, improve the clinical trial planning process, and increase the likelihood of success for trials under development.

“With the clinical trial landscape changing so dramatically, it’s essential that professionals have as much connected, specific data in their hands as possible,” said Steve Goldstein, CEO of ResoluteAI. “Our new Clinical Trials Analytics package connects academic research to specific trials, identifies Principal Investigators, accelerates competitive intelligence, and gathers evidence for protocols. Our goal is to reduce company investment risk in clinical trials by making sure no information is missed."

By tagging clinical trials with taxonomies such as ICD-10 (diseases and injuries), MeSH (Medical Subject Headings), and RxNorm (drugs and substances), ResoluteAI can connect clinical trials to academic publications, patents, and other datasets. By integrating Clinical Trials Analytics into ResoluteAI’s knowledge graph, relationships between clinical trials and sponsors, facilities, Principal Investigators, and drugs become visible and expandable. This functionality facilitates:

• Evaluation and exploration of facilities conducting clinical trials
• Exploration of clinical trials using the same drug
• Identifies Principal Investigator relationships to organizations through clinical trial sponsors and facilities

Foundation’s robust analytics and visualization capabilities can be used to review and summarize multiple trials for the same indication, which can be aggregated and presented to colleagues using ResoluteAI’s Collections feature. See an example here. Data silos plague the clinical trials research process. ResoluteAI’s Clinical Trials Analytics package eliminates silos and provides a connected view of key databases required for clinical trials development.

About ResoluteAI

ResoluteAI is the research platform for science. Foundation enables commercial science enterprises to search aggregated scientific, regulatory, and business databases simultaneously. Nebula is our enterprise search tool for science. Combined with our interactive analytics and downloadable visualizations, ResoluteAI makes connections that lead to breakthrough discoveries. Used by scientific organizations around the world, ResoluteAI won the BCS Search Industry Award for Most Promising Start-Up in 2021.

For more information about ResoluteAI, please visit our website at www.resolute.ai.